Literature DB >> 10780575

Pepsin and the esophagus.

B I Hirschowitz1.   

Abstract

Esophagitis results from excessive exposure of the esophagus to gastric juice through an ineffective or dysfunctional lower esophageal sphincter mechanism. A possible role of pepsin in damaging the esophageal mucosa with consequent esophagitis may be examined directly by testing pepsin under various conditions in experimental models of esophagitis. Since gastric juice contains both acid and pepsin, all experiments examine separately effects of perfusion of the esophagus by acid without and with pepsin in various combinations. Acid perfusion alone at concentrations represented by pH 1.3 or above does not produce esophagitis. The addition of pepsin to acid between pH 1 and 3.5 causes considerable acute esophageal damage. Outside the proteolytic range, i.e., higher than pH 3.5, pepsin does not damage the esophagus. The damage caused by acidified pepsin may be made much worse by the further addition of aspirin or other NSAIDs, presumably by further breaking down mucosal barriers.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10780575      PMCID: PMC2579005     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  32 in total

1.  The activation of pepsinogen inside the gastric mucosa caused by the hydrogen ion back diffusion during the course of aspirin ulceration.

Authors:  K Ohe; N Ueno; H Yokoya; A Miyoshi
Journal:  Hiroshima J Med Sci       Date:  1979-03

2.  Isolation and characterization of basement membrane collagen from human placental tissue. Evidence for the presence of two genetically distinct collagen chains.

Authors:  T F Kresina; E J Miller
Journal:  Biochemistry       Date:  1979-07-10       Impact factor: 3.162

3.  Role of acid and pepsin in acute experimental esophagitis.

Authors:  H I Goldberg; W J Dodds; S Gee; C Montgomery; F F Zboralske
Journal:  Gastroenterology       Date:  1969-02       Impact factor: 22.682

4.  Adaptation of esophageal mucosa to acid- and pepsin-induced damage: role of nitric oxide and epidermal growth factor.

Authors:  A I Lanas; J M Blas; J Ortego; J Soria; R Sáinz
Journal:  Dig Dis Sci       Date:  1997-05       Impact factor: 3.199

5.  Daily omeprazole surpasses intermittent dosing in preventing relapse of oesophagitis: a US multi-centre double-blind study.

Authors:  S J Sontag; M Robinson; W Roufail; B I Hirschowitz; S M Sabesin; W C Wu; J Behar; W L Peterson; K R Kranz; A Tarnawski; Y Dayal; R Berman; T J Simon
Journal:  Aliment Pharmacol Ther       Date:  1997-04       Impact factor: 8.171

6.  Oesophageal histology in long term users of non-steroidal anti-inflammatory drugs.

Authors:  A S Taha; S Dahill; I Nakshabendi; F D Lee; R D Sturrock; R I Russell
Journal:  J Clin Pathol       Date:  1994-08       Impact factor: 3.411

7.  Effect of carbacholine and urecholine on pentagastrin-stimulated gastric secretion in healthy subjects.

Authors:  M Roland; A Berstad; I Liavåg
Journal:  Scand J Gastroenterol       Date:  1975       Impact factor: 2.423

8.  Gastric secretion of acid and pepsin in patients with esophageal stricture and appropriate controls.

Authors:  B I Hirschowitz
Journal:  Dig Dis Sci       Date:  1996-11       Impact factor: 3.199

9.  Gastric acid and pepsin secretion in patients with Barrett's esophagus and appropriate controls.

Authors:  B I Hirschowitz
Journal:  Dig Dis Sci       Date:  1996-07       Impact factor: 3.199

Review 10.  Medical management of esophageal reflux.

Authors:  B I Hirschowitz
Journal:  Yale J Biol Med       Date:  1994 May-Aug
View more
  7 in total

1.  Essential role of pepsin in pathogenesis of acid reflux esophagitis in rats.

Authors:  Kenji Nagahama; Masanori Yamato; Hikaru Nishio; Koji Takeuchi
Journal:  Dig Dis Sci       Date:  2006-02       Impact factor: 3.199

2.  Stromal cells participate in the murine esophageal mucosal injury response.

Authors:  Anisa Shaker; Jana Binkley; Isra Darwech; Elzbieta Swietlicki; Keely McDonald; Rodney Newberry; Deborah C Rubin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-01-31       Impact factor: 4.052

Review 3.  Animal model of acid-reflux esophagitis: pathogenic roles of acid/pepsin, prostaglandins, and amino acids.

Authors:  Koji Takeuchi; Kenji Nagahama
Journal:  Biomed Res Int       Date:  2014-02-02       Impact factor: 3.411

4.  Prevalence of Gastroesophageal Reflux in Cats During Anesthesia and Effect of Omeprazole on Gastric pH.

Authors:  R S Garcia; P C Belafsky; A Della Maggiore; J M Osborn; B H Pypendop; T Pierce; V J Walker; A Fulton; S L Marks
Journal:  J Vet Intern Med       Date:  2017-04-19       Impact factor: 3.333

5.  The Role of Salivary Pepsin in the Diagnosis of Gastroesophageal Reflux Disease (GERD) Evaluated Using High-Resolution Manometry and 24-Hour Multichannel Intraluminal Impedance-pH Monitoring.

Authors:  Zihao Guo; Yanhong Wu; Jing Chen; Shutian Zhang; Chuan Zhang
Journal:  Med Sci Monit       Date:  2020-11-21

6.  Effect of acid suppression therapy on gastroesophageal reflux and cough in idiopathic pulmonary fibrosis: an intervention study.

Authors:  Claire E Kilduff; Melanie J Counter; Gareth A Thomas; Nicholas K Harrison; Benjamin D Hope-Gill
Journal:  Cough       Date:  2014-04-30

7.  ACVIM consensus statement: Support for rational administration of gastrointestinal protectants to dogs and cats.

Authors:  Stanley L Marks; Peter H Kook; Mark G Papich; M K Tolbert; Michael D Willard
Journal:  J Vet Intern Med       Date:  2018-10-31       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.